Aehr Test Systems (NASDAQ:AEHR) Shares Gap Up – Should You Buy?

Aehr Test Systems (NASDAQ:AEHR)’s stock price gapped up prior to trading on Thursday . The stock had previously closed at $73.22, but opened at $84.66. Aehr Test Systems shares last traded at $86.6760, with a volume of 2,615,210 shares traded.

Key Aehr Test Systems News

Here are the key news stories impacting Aehr Test Systems this week:

• Positive Sentiment: Record $41M hyperscale AI production order — the follow‑on order is for package‑level burn‑in of custom AI ASICs and is described as the largest in company history, providing a clear near‑term revenue and capacity catalyst. Accesswire: Record $41M order
• Positive Sentiment: Bookings/backlog strength tied to AI/data‑center demand — company updates and coverage report second‑half bookings exceeding ~$92M and a record backlog, supporting upside to FY2027 revenue if orders convert. Benzinga: record deal & bookings
• Positive Sentiment: Analyst optimism and higher price targets — recent upgrades and bumped targets have reinforced investor interest and helped attract institutional/retail flows. MSN: price target increase
• Positive Sentiment: Technical/momentum factors may amplify moves — a recent golden‑cross and elevated short interest increase the likelihood of follow‑through and short covering when positive headlines arrive. Seeking Alpha: movers summary
• Neutral Sentiment: Volatility and coverage: several outlets note extreme YTD moves (one headline cites a 300% move) — useful as context for sentiment but not a direct fundamental change. InsiderMonkey: AEHR up 300%
• Neutral Sentiment: Mixed quarterly fundamentals — AEHR beat EPS slightly but missed revenue; execution to convert large bookings into sustained, profitable growth remains the key risk. MarketBeat: quarterly results
• Negative Sentiment: Clustered insider selling — multiple executives and directors disclosed sizable share sales (including director and C‑suite transactions in mid‑April), which can create near‑term selling pressure and raise investor questions about insider conviction. InsiderTrades: insider selling
• Negative Sentiment: Media and aggregation highlight insider liquidity events — coverage emphasizing millions in insider proceeds can weigh on sentiment even if some sales are routine or for tax purposes. TipRanks: insider sell-off

Analyst Upgrades and Downgrades

A number of analysts have commented on AEHR shares. Lake Street Capital reiterated a “buy” rating on shares of Aehr Test Systems in a report on Wednesday, April 8th. William Blair upgraded Aehr Test Systems from a “market perform” rating to an “outperform” rating in a research report on Monday, March 2nd. Wall Street Zen raised Aehr Test Systems from a “strong sell” rating to a “sell” rating in a report on Saturday, April 11th. Weiss Ratings reiterated a “sell (d)” rating on shares of Aehr Test Systems in a research report on Wednesday, January 21st. Finally, Craig Hallum raised Aehr Test Systems from a “hold” rating to a “buy” rating and set a $68.00 price objective on the stock in a research note on Wednesday, April 8th. Three investment analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the company. According to MarketBeat, the stock has a consensus rating of “Hold” and a consensus price target of $68.00.

Aehr Test Systems Price Performance

The company has a market capitalization of $2.64 billion, a PE ratio of -220.68 and a beta of 2.28. The business’s 50 day simple moving average is $42.81 and its 200 day simple moving average is $31.03.

Aehr Test Systems (NASDAQ:AEHR) last posted its quarterly earnings results on Tuesday, April 7th. The semiconductor company reported ($0.05) earnings per share for the quarter, beating the consensus estimate of ($0.07) by $0.02. The business had revenue of $10.31 million during the quarter, compared to analysts’ expectations of $10.85 million. Aehr Test Systems had a negative net margin of 25.23% and a negative return on equity of 7.15%. As a group, analysts anticipate that Aehr Test Systems will post 0.1 EPS for the current year.

Insider Buying and Selling

In related news, Director Howard T. Slayen sold 25,000 shares of the firm’s stock in a transaction dated Friday, April 17th. The stock was sold at an average price of $85.00, for a total transaction of $2,125,000.00. Following the completion of the transaction, the director directly owned 178,328 shares in the company, valued at $15,157,880. This trade represents a 12.30% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available through this link. Also, insider Donald P. Richmond II sold 17,011 shares of the stock in a transaction dated Tuesday, April 14th. The stock was sold at an average price of $73.18, for a total transaction of $1,244,864.98. Following the sale, the insider directly owned 181,512 shares in the company, valued at $13,283,048.16. This represents a 8.57% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 335,724 shares of company stock valued at $23,701,156 over the last three months. Company insiders own 6.80% of the company’s stock.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in AEHR. Royal Bank of Canada grew its holdings in shares of Aehr Test Systems by 262.7% in the first quarter. Royal Bank of Canada now owns 50,207 shares of the semiconductor company’s stock valued at $365,000 after purchasing an additional 36,364 shares in the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. lifted its holdings in Aehr Test Systems by 8.5% during the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 17,225 shares of the semiconductor company’s stock worth $126,000 after buying an additional 1,344 shares in the last quarter. JPMorgan Chase & Co. boosted its position in Aehr Test Systems by 7.9% in the 2nd quarter. JPMorgan Chase & Co. now owns 15,576 shares of the semiconductor company’s stock valued at $201,000 after buying an additional 1,145 shares during the period. Legal & General Group Plc boosted its position in Aehr Test Systems by 110.8% in the 2nd quarter. Legal & General Group Plc now owns 6,882 shares of the semiconductor company’s stock valued at $89,000 after buying an additional 3,617 shares during the period. Finally, Rhumbline Advisers grew its stake in shares of Aehr Test Systems by 3.1% in the second quarter. Rhumbline Advisers now owns 41,466 shares of the semiconductor company’s stock worth $536,000 after acquiring an additional 1,254 shares in the last quarter. Institutional investors and hedge funds own 69.69% of the company’s stock.

Aehr Test Systems Company Profile

Aehr Test Systems develops, manufactures and sells semiconductor test and burn-in equipment used by device manufacturers to ensure quality and reliability of integrated circuits. Its products are designed for wafer-level reliability assessment, functional test and stress screening of memory devices, system-on-chips, optical components and power semiconductors. By focusing on wafer-level burn-in and testing processes, the company helps reduce cost and improve yield for high-volume semiconductor production.

The company’s product portfolio includes FOX series wafer probe test and burn-in systems as well as ABTS burn-in ovens.